12370087.txt 0 inhibition     mek1erk pathway reduces arachidonic acid release independently   cpla2 phosphorylation   translocation
12370087.txt 1 abstract  background    85kda cytosolic phospholipase a2 cpla2 mediates arachidonic acid aa release   mdck cells although calcium   mitogenactivated protein kinases regulate cpla2   correlation   cpla2 translocation   phosphorylation   mapk activation   aa release   unclear  results  mek1 inhibition   u0126 inhibited aa release   response   atp   ionomycin   directly correlated   inhibition   erk activation       phosphorylation   cpla2   ser505   was only partially inhibited   erk inhibition inhibition   aa release   u0126 was still observed when stoichiometric phosphorylation   cpla2   ser505 was maintained   activating p38   anisomycin translocation kinetics   wildtype cpla2   cpla2 containing s505a   s727a mutations   golgi were similar   response   atp   ionomycin   were   affected   u0126  conclusions  these results suggest     ability   cpla2   hydrolyze membrane phospholipid   reduced   inhibition     mek1erk pathway       reduction   activity   independent   cpla2 phosphorylation   translocation   membrane   results also demonstrate   cpla2 mutated     phosphorylation sites ser505   ser727 translocated   similar kinetic   wildtype cpla2
12370087.txt 2 anisomycin arachidonic acid calcium cytosolic phospholipase a2 erk fluorescent proteins phosphorylation mek u0126 translocation
12370087.txt 3 cytosolic pla2 specifically hydrolyzes sn2 arachidonate   phospholipid providing   precursors   many different lipid mediators including prostaglandins   leukotrienes  these lipid metabolites play   role   acute inflammatory responses   also regulate normal physiological processes certain prostaglandins   required   female reproduction   kidney function  because   its important role   controlling levels   arachidonic acid aa much attention has been focused     regulation   cpla2 activation   particular emphasis     role   its phosphorylation   ca2mediated translocation  cpla2   regulated   controlling its cellular localization   access   membranephospholipid substrate an amino terminal calciumdependent lipid binding calb   c2 domain regulates ca2mediated cpla2 translocation   intracellular membranes    vitro membrane docking via   c2 domain   necessary   sufficient   catalysis   release   aa  binding   calcium ions     cpla2 c2 domain   essential     lipid association   vitro    translocation   vivo    response   an increase   ca2  cpla2 translocates     golgi   er however translocation   golgi occurs     lower ca2  protein kinase pathways play major roles   cpla2 activation   regulation     mitogenactivated protein kinase kinase mek extracellularsignal regulated kinase erk signaling pathway has received particular attention cpla2   phosphorylated   mitogen activated protein map kinases including p42p44 erks   p38   ser505   vitro      response   receptor stimulation    addition   phosphorylation   map kinase   has been shown   cpla2   also phosphorylated   ser727   mapkinteracting kinase   mnki      ser515   calciumcalmodulindependent protein kinase ii  phosphorylation   these sites may also play   role   regulating cpla2 function   certain cell models phosphorylation   ser505 has been extensively studied because     readily detected due     characteristic electrophoretic mobility shift when analyzed   sdspage    importance   ser505 phosphorylation   regulating cpla2 has been demonstrated   different cells     vitro models   using cpla2 containing   s505a mutation  however   mechanism whereby ser505 phosphorylation regulates cpla2 function has been elusive   vitro studies have demonstrated   dephosphorylated cpla2   catalytically active     ser505 phosphorylation increases activity   only 30 percent    contrast cells expressing   cpla2 s505a mutation fail   release aa   response     low dose   calcium ionophore   release similar amounts   aa   cells expressing wildtype cpla2   response   high dose ionophore    these studies   has been suggested   cpla2 ser505 phosphorylation may have   role   regulating translocation    previous study demonstrated translocation   cpla2 s505a   response   ca2 ionophore   did   address   kinetics   translocation translocation   response     physiological agonist   differences   targeting    better understand   regulation   cpla2     mek1erk pathway   ca2   investigated   effect   mek inhibitors   aa release cpla2 phosphorylation   ser505 cpla2 translocation kinetics   ca2  increase   madindarby canine kidney mdck cells   found   inhibition   mek1   u0126 significantly inhibited aa release     was correlated   inhibition   erk activation however mek inhibition only partially affected cpla2 phosphorylation   had   effect     kinetics   ca2mediated cpla2 translocation   membrane   addition using cells expressing wildtype cpla2   cpla2   s505a   s727a mutations   was found   translocation kinetics   membrane targeting   response   atp   ionomycin was similar   wildtype cpla2 these data suggest   mek1 inhibition reduces cpla2 catalytic activity   aa release independently   phosphorylation   translocation
12370087.txt 4 effect   mek inhibition   aa release erk activation   cpla2 ser505 phosphorylation    study   role     mek1erk pathway   cpla2 activation quiesced mdck cells were treated     mek1 inhibitor u0126     effect   aa release erk activation   cpla2 gel shift determined    equivalence     imaging studies cells expressing egfpcpla2 were used     experiments egfpcpla2 was expressed   similar levels   endogenous enzyme   did   contribute significantly   aa release   stably transfected cells however egfpcpla2   functional since   dosedependently catalyzes release   aa when expressed   cells   lack endogenous cpla2 such   sf9 cells    immortalized mouse lung fibroblasts   cpla2alpha knockout mice    order   enhance aa release   cells containing endogenous cpla2     necessary   overexpress   enzyme several fold   previously reported  cytosolic pla2 has been shown   mediate ca2induced aa release   mdck cells treated   atp   iono   experiments using   group iv cpla2alphaspecific inhibitor pyrrolidine1    measure cpla2 mediated aa release egfpcpla2transfected mdck cells labeled   3haa were incubated   03 1   10 mum u0126   15 min prior   stimulation   100 mum atp 1 mum iono   10 mum iono aa release was measured   3 min because   have shown   atp   ionostimulated aa release peaks between 3   5 min poststimulation  agonistinduced aa release was inhibited dosedependently   u0126      highest u0126 concentration used 10 mum reducing aa release   72 80     agonists    inhibition was independent     total amount   aa released since aa release stimulated   10 mum iono was 3fold greater than release stimulated   1 mum iono   100 mum atp     percent inhibition   u0126 was similar treatment   mdck cells   30 mum pd098059   less potent inhibitor   mek  resulted     50 reduction   aa release   response   100 mum atp 1 mum iono   10 mum iono data   shown thus   mdck cells mek1 inhibition significantly reduces   ability   cpla2   hydrolyze aa   membrane phospholipids figure 1   effect   mek inhibition   aa release erk inhibition   cpla2 ser505 phosphorylation  effect   mek inhibition   aa release erk inhibition   cpla2 ser505 phosphorylation   egfpcpla2transfected cells were incubated     indicated concentrations   u0126   15 min prior   stimulation   100 mum atp 1 mum iono   10 mum iono aa release was assayed   3 min results show   average  sd   3 experiments error bars   down   atp   clarity protein extracts   egfpcpla2transfected cells incubated     indicated concentrations   u0126   15 min prior   stimulation   100 mum atp 1 mum iono   10 mum iono   3 min were subjected   immunoblotting using b antiphosphoerk   c anticpla2 polyclonal antibodies results     3   5 independent experiments table 1  inhibition   aa release   10 mum u0126 see experimental procedures   experimental conditions   methods   determine aa release percent inhibition   aa release after 3 min   agonist treatment   average  s    n experiments preformed   duplicate   effect   mek1 inhibition   activation   p42p44 erk measured   immunoblot analysis using phosphospecific antibodies   cells treated   u0126   stimulated   above was determined  work     laboratory has shown   recognition   erk   antiphosphoerk antibodies correlates   an increase   erk activity  interestingly   antiphosphoerk immunoblots revealed   erks were constitutively activated   untreated quiesced mdck cells   activation was   enhanced further   atp   iono fig  left panel erk activation was diminished   increasing concentrations   u0126   was quantitatively inhibited after 15 min incubation   10 mum u0126 u0126 decreased erk activation following atp   iono stimulation     same fashion     unstimulated cells consequently   was   direct correlation between   reduction   aa release    inhibition   erk activation    mdck cells treated   u0126 because cpla2     target     mek1erk signaling cascade   assayed   effect   mek1 inhibition   u0126   cpla2 phosphorylation   analyzing gel shift   cpla2 phosphorylation   ser505 results     retardation   its electrophoretic mobility gel shift    unstimulated cells egfptagged   endogenous cpla2 were nearly completely gel shifted indicating   most cpla2 was phosphorylated   ser505      consistent     observation   erks   constitutively activated incubation   u0126 resulted     partial reversal     gel shift although   10 mum u0126 approximately half   cpla2 remained phosphorylated   ser505 thus unlike   quantitative effect   u0126   erk activation inhibition   mek1   u0126 only partially reversed   gel shift   cpla2   reversal     gel shift was similar   cells treated   atp   1   10 mum iono due     increased molecular weight     egfptagged cpla2   two forms   cpla2 did   separate   well making   gel shift   difficult   visualize   generally mirrored   gel shift characteristics     endogenous cpla2 these results suggest     response   mek1 inhibition       quantitative dosedependent decrease   aa release   correlates well     loss   erk activation         extent   cpla2 ser505 phosphorylation   further investigate whether   mek1erk pathway played   role   regulating aa release independent   ser505 phosphorylation   treated cells   anisomycin   activates   mapk homolog p38       mek1erk pathway  activation   p38   response   anisomycin treatment was analyzed   immunoblotting using an antiphosphop38 antibody    immunoblots demonstrate   30 min treatment   25 ngml anisomycin resulted   phosphorylation   p38   unstimulated mdck cells     cells treated   atp   iono atp   ionomycin treatment     absence   anisomycin only weakly increased p38 phosphorylation   expected   mek inhibitor u0126 did   significantly affect anisomycinstimulated p38 phosphorylation   control experiments anisomycin treatment did   induce erk activation nor interfere   inhibition   erk activation   10 mum u0126 treatment    have previously reported   p38   also selectively activated   anisomycintreated macrophages  importantly pretreatment   cells   30 min   anisomycin resulted   maintenance     cpla2 gel shift     presence   u0126   unstimulated cells     cells stimulated   atp   1   10 mum iono  aa release assays show     mdck cells treated   anisomycin u0126 resulted   an aa release reduction   67 76  similar     inhibition observed without anisomycin these results demonstrate   activation     mek1erk pathway   required   aa release even under conditions where cpla2 ser505 phosphorylation   maintained suggesting an alternative role     mek1erk pathway   regulating cpla2 figure 2   effect   anisomycin   u0126   aa release erk inhibition   cpla2 ser505 phosphorylation  effect   anisomycin   u0126   aa release erk inhibition   cpla2 ser505 phosphorylation egfpcpla2transfected cells were incubated   25 ngml anisomycin   30 min 10 mum u0126   15 min     both drugs prior   stimulation   100 mum atp 1 mum iono   10 mum iono protein extracts were subjected   immunoblotting using   antiphosphop38 b antiphosphoerk   c anticpla2 antibodies   aa release   response   100 mum atp 1 mum iono   10 mum iono     presence   absence     inhibitors anisomycin did   stimulate aa release   unstimulated cells   results show average  sem   3   5 independent experiments  ca2  increase   independent   mek1erk pathway  one explanation     decrease   aa     u0126 inhibits ca2  mobilization   response   atp   iono thereby preventing translocation   cpla2   chick ventricular myocytes inhibition   mek1erk   pd98059 inhibits zinterolmediated aa release   also inhibits zinterolinduced stimulation   ca2  cycling   electrically stimulated cells    mdck cells extracellular atp acts via p2y2 receptors   elicit an ip3mediated ca2  increase    iono acts   increase ca2    permeabilizing cell membranes   ca2   determine   effect   u0126   intracellular ca2 mobilization   100 mum atp   10 mum iono   utilized singlecell fluorescence microscopy   cells loaded     calcium indicator fura2 analysis     ca2  increase   individual cells reveals   heterogeneity     response   atp although most cells exhibited ca2  spikes   similar magnitude   duration fig     thin lines analysis     ca2  increase   several cells fig     thick line revealed   although   duration     ca2  increase elicited   atp   control cells was   same       u0126treated cells approximately 3 4 min   amplitude     ca2  increase was slightly higher 20     u0126treated cells iono elicited   sustained supraphysiological ca2  increase   cells   was also slightly enhanced   u0126 fig     these experiments demonstrate   u0126 does   decrease ca2  mobilization     inhibition   aa release   u0126 cannot   ascribed     failure   ca2  mobilization figure 3   effect   u0126   atp   ionoinduced ca2  change  effect   u0126   atp   ionoinduced ca2  change mdck cells were loaded     fluorescent ca2 indicator fura2 incubated   10 mum u0126   vehicle   15 min   stimulated   100 mum atp   10 mum iono graphs show changes   ca2  expressed     340380 ratio   fura2 fluorescence   respect   time   8 individual cells thin traces       average   16 cells thick trace treated     u0126   atp b vehicle   atp c u0126   iono     vehicle   iono results   representative   4 independent experiments   each condition   analysis   several cells per experiment  cpla2 translocation   independent   mek1erk pathway    effect   inhibition     mek1erk pathway   u0126   translocation   cpla2 was investigated although       inhibition   ca2  release   u0126   little effect   ser505 phosphorylation     possible   mek1 inhibition   u0126 prevents cpla2 translocation   another mechanism   investigate   possibility cells were transfected     wildtype cpla2 fused   eyfp eyfpcpla2     distribution   eyfpcpla2 was imaged   response   ca2  transients elicited   atp   sustained ca2  elevations elicited   iono     presence   absence   u0126 following stimulation   100 mum atp   was   rapid translocation   eyfpcpla2   golgi   was unaffected   u0126    response   physiological agonists   elicit transient ca2  changes only   small fraction     cpla2 translocates   observation   consistent     previous results    has been demonstrated   hirabayashi et al  most studies   cpla2 translocation have utilized ionophore   elicits   large supraphysiological sustained increase   ca2    agonists   produce   sustained ca2  increase under these conditions   large proportion   cpla2 binds   membrane these studies show extensive translocation     endoplasmic reticulum er nuclear envelope   golgi    found   u0126 also failed   alter extensive eyfpcpla2 translocation   golgi   er   response 10 mum iono  these results demonstrate   mek inhibition has   effect   cpla2 translocation figure 4   effect   u0126   translocation   eyfpcpla2 following atp   iono stimulation  effect   u0126   translocation   eyfpcpla2 following atp   iono stimulation cells expressing eyfpcpla2 were incubated   10 mum u0126 b     vehicle   c   15 min prior   stimulation   100 mum atp   b   10 mum iono c   representative frames   timelapse images show   distribution   eyfpcpla2 fluorescence before   after stimulation results   representative   4 independent experiments   analysis   several cells per experiment  translocation   phosphorylation site mutants s505a   s727a   similar   wildtype cpla2  phosphorylation   cpla2   ser505 has been hypothesized   play   role   ca2mediated translocation since ser505 phosphorylation   required   cpla2mediated aa release   response   lowdose     highdose ionophore  translocation   cpla2 s505a   cho cells has been reported   response   ionophore stimulation      effect   ser505 phosphorylation     kinetics   translocation targeting     response     physiological agonist was   investigated mdck cells were cotransfected   eyfpcpla2     cpla2     s505a mutation fused   ecfp ecfpcpla2s505a using dual eyfpecfp imaging   were able   directly compare translocation   both constructs     same cell   resting distribution   eyfpcpla2 was similar       ecfpcpla2s505a     response   atp followed   iono   pattern   translocation   eyfpcpla2 was similar   ecfpcpla2s505a fig  panels     b   analysis     increase   fluorescence     golgi   respect   time demonstrates     rates   translocation   cpla2   cpla2s505a elicited   atp followed   iono   very similar    previously reported    cpla2 s727a mutation has   similar phenotype   aa release     s505a mutation   ser727 was found     phosphorylated   tandem   ser505 imaging experiments were performed using eyfpcpla2   ecfpcpla2s727a     found     distribution   eyfpcpla2 was identical       ecfpcpla2s727a before   after stimulation   10 mum iono fig 7 panels     b   analysis     increase   fluorescence     golgi   respect   time demonstrates     rates   translocation   cpla2     cpla2s727a elicited   iono   very similar  figure 5   translocation   ecfpcpla2s505a following atp   iono stimulation  translocation   ecfpcpla2s505a following atp   iono stimulation cells expressing ecfpcpla2s505a   eyfpcpla2 were stimulated   atp   iono ecfp   eyfp fluorescence images were taken   3 s intervals representative frames   timelapse images show   distribution   eyfpcpla2   ecfpcpla2s505a fluorescence before   30 s after addition   100 mum atp followed   addition   10 mum iono   1 min panels     b c fluorescent protein fp fluorescence     area     golgi inset was analyzed   respect   time before   after atp   iono addition arrows   overlay     75 s images   panels     b results   representative   5 independent experiments   analysis   several cells per experiment figure 6   translocation   ecfpcpla2s727a following iono stimulation  translocation   ecfpcpla2s727a following iono stimulation cells expressing ecfpcpla2s727a   eyfpcpla2 were stimulated   iono representative frames   timelapse images show   distribution   eyfpcpla2   ecfpcpla2s727a fluorescence before   13 s after addition   10 mum iono panels     b c fluorescent protein fp fluorescence     area     golgi inset was analyzed   respect   time before   after iono addition arrow   overlay     77 s images   panels     b results   representative   4 independent experiments   analysis   several cells per experiment
12370087.txt 5   mek1erk pathway regulates cpla2   erks phosphorylate cpla2   ser505   results     study demonstrate     pathway   required   cpla2mediated aa release independent   ser505 phosphorylation   extend   previous work   macrophages    demonstrating     alternative role     mek1erk pathway     involved   regulating ca2  change   cpla2 translocation kinetics   targeting     required   optimal hydrolytic activity   aa release   results shown here demonstrate   inhibition   mek   u0126 quantitatively inhibits both erk phosphorylation   aa release   mdck cells   response   ca2  mobilization   mek inhibitor pd098059   less potent inhibitor  also inhibited atp   ionoinduced aa release data   shown erk was found     constitutively phosphorylated     study using mdck cells   atcc   contrast     has been reported previously   mdckd1   subclone   mdck selected   adrenergic receptor expression  however   side side comparison   mdck cells   atcc     mdckd1 subclone kindly provided   dr paul insel ucsd demonstrated constitutive activation   erks when both   grown   low density   shown however   high density erks   less active   can   further activated   phorbol ester   shown   mdckd1 cells without constitutively active erks aa release   delayed after ca2  mobilization     temporally correlated   erk activation  whereas   mdck cells   constitutively active erks aa release   rapid   significant aa release measured 30 s after ca2  increase    temporal correlation between aa release   erk activation has also been reported   cho cells   response   paf stimulation  these results support   observations made here   erk activity   required   phospholipid hydrolysis independently   cpla2 translocation cpla2mediated aa release must   preceded   translocation     enzyme   its membrane substrate       ca2dependent process       function     calciumdependent lipidbinding c2 domain cpla2 translocates primarily   golgi   response     transient ca2  changes     golgi   er   response     sustained ca2  increase    reduction   aa release   mek inhibition did   involve   failure   ca2  release   translocation these results show   translocation   necessary     sufficient   optimum hydrolytic activity measuring cpla2 translocation       trivial matter when investigating mechanisms   aa release   example cpla2 constructs     s505a mutation have long been recognized   unable   support aa release   response   physiological agonists   lowdose ionophore when transfected   cells   contrast cpla2 s505a   active   vitro   phosphorylation only modestly increases   activity     enzyme  interestingly   inhibitory effect     s505a mutation   aa release   obviated     high ca2  increase   light   these observations     possible   ser505 phosphorylation may alter   ca2  sensitivity     enzyme its rate   translocation its intracellular targeting     has been previously suggested    ability   cpla2   release     nonmembrane sequestering agent although one report has shown   cpla2 s505a translocates   cho cells   response   ionophore   were able   directly compare rates   translocation between cpla2   cpla2 s505a     physiological agonist   found   difference between translocation rates   intracellular targeting   also demonstrated     was   difference   translocation rates   intracellular targeting between wildtype cpla2   cpla2 s727a   has   same phenotype   s505a   regard   aa release when transfected into cells thus   role   cpla2 phosphorylation   mediating aa release remains unclear although   alternative mechanism whereby   mek1erk pathway regulates cpla2     known     possible     affects membrane properties    cpla2 conformation   promotes optimal hydrolytic activity     also possible     alternative mechanism   due   phosphorylation   cpla2     novel site     kinase     downstream     mek1erk pathway   phosphorylation     regulatory protein
12370087.txt 6 translocation   membrane     critical regulatory step     action   cpla2 because     necessary   access   substrate     study   demonstrate however   association   cpla2   membrane when phosphorylated   ser505     sufficient   its full activity   vivo     demonstrated     results showing   inhibition     mek1erk pathway significantly blocks aa release   has   effect   ca2  mobilization   cpla2 translocation   targeting diminution   aa release   mek1erk   also independent   cpla2 phosphorylation   ser505 consequently   results demonstrate   living cells     translocation process   subsequent catalytic activity     membrane   two independently regulated steps
12370087.txt 7 fluorescent proteincpla2 fusion constructs  dna encoding   fulllength human cpla2 was cloned into   vector pegfpc3 clontech   create pegfpcpla2   previously described    xbaipsti fragment     cpla2alpha clone containing s505a   s727a mutations  was inserted into an xbaipsti site   pegfpcpla2   generate pegfpcpla2s505a   pecfpcpla2s727a different fluorescentprotein tagged constructs were produced   exchanging   nheibsrgi fragment containing   fluorescent protein coding sequence between egfp eyfp   ecfp   constructs were confirmed   sequencing  cell culture  mdck cells obtained   atcc were cultured   dmem containing 10 fbs 100 uml penicillin 100 mugml streptomycin 0292 mgml glutamine growth medium   5 co2   37c subconfluent cells 5 x 103 cellscm2 were transfected   2 mug     relevant plasmid using fugene6 boehringer mannheim   dmem containing 02 bsa 100 uml penicillin 100 mugml streptomycin 0292 mgml glutamine serumfree medium following   manufacturers protocol stable lines expressing egfpcpla2 were generated   growing transfected cells   growth medium   3   supplementing   growth medium   5 mgml geneticin antibiotic g418sulfate   culturing   an additional 2 wk   geneticin cells expressing egfp fluorescence were selected using   fluorescenceactivated cell sorter   egfppositive cells were maintained   growth medium supplemented   5 mgml geneticin   imaging studies mdck cells were plated   glassbottomed 35 mm culture dishes mattek   5 x 103 cellscm2   growth medium   incubated overnight transfected     relevant plasmids changed into serumfree medium   quiesce   cells incubated overnight   used   next day  immunoblotting  stable egfpcpla2 transfectants were grown   100 mm dishes   5 x 103 cellscm2   growth medium   one day   quiesced   serumfree medium overnight cells were scraped into icecold lysis buffer 50 mm hepes ph 74 150 mm sodium chloride 15 mm magnesium chloride 10 glycerol 1 triton x100 1 mm egta 200 mum sodium vanadate 10 mm tetrasodium pyrophosphate 100 mm sodium fluoride 10 mugml leupeptin   10 mugml aprotinin lysates were centrifuged   15000 x g   15 min   protein concentration     supernatant was determined     bicinchoninic acid method laemmli electrophoresis sample buffer 5x was added     lysates   sdspolyacrylamide gel electrophoresis   immunoblotting were performed using 35 mug lysate protein phosphospecific antibodies   erk   p38   rabbit polyclonal antibody   cpla2  dual imaging microscopy   fluorescent protein translocation    order   compare   characteristics   fulllength cpla2   cpla2s505a   cpla2s727a translocation while controlling   cell cell heterogeneity   used   dual cfpyfp imaging approach eyfpcpla2ecfpcpla2s505a   pecfpcpla2s727atransfected mdck cells grown   mattek plates were quiesced overnight   serumfree medium washed     incubated   hanks balanced salt solution hbss additionally buffered   25 mm hepes ph 74 hhbss cells were imaged using an olympus inverted microscope equipped     60x 125 na oil immersion objective cfp   yfp emission filters chroma     sutter filter wheel   dual cfpyfp dichroic mirror     till imago ccd camera till photonics excitation light   430   510 nm   cfp   yfp respectively was provided using   polychrome iv monochromator till photonics tillvision software was used   acquisition   analysis bleach values   ecfp   eyfp were calculated   determining   backgroundcorrected fluorescence     entire cell   respect   time   normalizing each value     initial value ecfpeyfp fluorescence changes   respect   time   regions   interest corresponding   an area   golgi membrane were determined   calculating   ftf0 where ft     background   bleachcorrected ecfp   eyfp fluorescence   time      f0     backgroundcorrected ecfp   eyfp fluorescence   time  0 s fluorescence was normalized     f0 value   resulted   ftf0 representing   fraction   total cell fluorescence   golgi final images were produced using adobe photoshop  calcium imaging  mdck cells grown   mattek plates were quiesced overnight   serumfree medium washed   hhbss containing 1 mm probenecid   incubated   5 mum fura2am calbiochem   hhbss 1 mm probenecid   1 dmso   45 min   37c cells were   washed   hhbss containing 1 mm probenecid   imaged after   30 min incubation   deesterification     fura2am singlecell imaging was performed     olympus system described above   using   40x 135 na oil immersion objective     fura2 dichroic mirror   emission filter chroma fura2 image pairs illuminated   340   380 nm were taken   1 hz   ca2  increase   expressed     ratio     backgroundcorrected fura2 fluorescence   340   380 nm   measurement   aa release    protocol   determining aa release   essentially   described  mdck cells stably expressing egfpcpla2 were plated   12well plates   5 x 103 cellscm2   incubated   growth medium overnight cells were   washed twice   serumfree medium   incubated   025 muci 3haawell   serumfree medium overnight u0126   vehicle was added   each well     cells were   incubated   15 min   37c   5 co2 cells were washed   remove unincorporated 3haa     incubated   hhbss supplemented   005 bsa   either u0126   vehicle cells were stimulated     agonist   choice     medium was collected   appropriate time points   medium was centrifuged   500 g   5 min     amount   radioactivity     supernatant was determined   scintillation counting cells were scraped   05 ml 01 triton x100   determining   total cellular radioactivity
12370087.txt 8 jhe carried out   ca   fp imaging studies participated     design   coordination     study   drafted   manuscript djf performed   aa release   western blot studies   participated     design   coordination     study ccl conceived     study participated   its design   coordination   participated   writing   draft   authors read   approved   final manuscript
12370087.txt 9 
